Distraction With Virtual Reality From Pain and Anxiety for Patients With Hematological Malignancies
Trial Parameters
Brief Summary
The goal of this clinical trial\] is to study the effectiveness of Virtual Reality (VR) in reducing pain and anxiety during painful procedures for patients with hematological malignancies The main question\[s\] it aims to answer are: Does VR effectively reduce pain during painful procedures for patients with hematological malignancies ? Does VR effectively reduce anxiety during painful procedures for patients with hematological malignancies ? Interventional group (intra-group comparaison): This design allows each patient to act as his own control.: The intervention consists of a complete sequence involving three phases: Period 1 (standard care), a washout period of at least seven days, and Period 2 (VR session). External control group (inter-group comparaison): Patients will be assigned to the intervention group first, and then a matching external control patient will be selected based on age and type of procedure.
Eligibility Criteria
Inclusion Criteria * being ≥ 6 years old * having a confirmed diagnosis of a hematological malignancy * undergoing at least one of the following procedures: Bone Marrow Biopsy, Bone Marrow Aspiration, Lumbar Puncture, Venipuncture, or Chemotherapy. Exclusion Criteria: * unstable or photosensitive epilepsy * hearing, visual, or inner ear impairments * severe psychiatric, cognitive, or mental disorders * Contagious diseases * Communication difficulties * Patients who withdraw consent * Patient who remove the VR headset during the procedure